Your browser doesn't support javascript.
loading
Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials.
Veitch, Zachary W; Shepshelovich, Daniel; Gallagher, Christina; Wang, Lisa; Abdul Razak, Albiruni R; Spreafico, Anna; Bedard, Philippe L; Siu, Lillian L; Minasian, Lori; Hansen, Aaron R.
Affiliation
  • Veitch ZW; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Shepshelovich D; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Gallagher C; Department of Internal Medicine, Sackler School of Medicine, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
  • Wang L; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Abdul Razak AR; Department of Biostatistics, University of Toronto, Toronto, ON, Canada.
  • Spreafico A; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Bedard PL; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Siu LL; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Minasian L; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Hansen AR; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
J Natl Cancer Inst ; 113(8): 980-988, 2021 08 02.
Article in En | MEDLINE | ID: mdl-33616650
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Patient Reported Outcome Measures / Neoplasms / Antineoplastic Agents Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: J Natl Cancer Inst Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Patient Reported Outcome Measures / Neoplasms / Antineoplastic Agents Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: J Natl Cancer Inst Year: 2021 Document type: Article Affiliation country: Country of publication: